10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for political campaigns.
FibroGen’s One Study For Duchenne Muscular Dystrophy Fails To Hit Main Goal
FibroGen Inc (NASDAQ: FGEN) announced topline data from the Phase 3 LELANTOS-1 trial of pamrevlumab for the treatment of non-ambulatory patients with Duchenne Muscular Dystrophy (DMD)
Benzinga’s Top Ratings Upgrades, Downgrades For June 2, 2023
Upgrades For Surgery Partners Inc (NASDAQ:SGRY), B of A Securities upgraded the previous rating of Neutral to Buy.…
FibroGen’s Return on Invested Capital Overview
Benzinga Pro data, FibroGen (NASDAQ:FGEN) reported Q1 sales of $36.16 million. Earnings fell to a loss of $76.70…
Earnings Scheduled For May 8, 2023
Companies Reporting Before The Bell
• HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.
FibroGen’s Anemia Candidate Fails In Myelodysplastic Syndrome Study
FibroGen Inc (NASDAQ:FGEN) released data from the MATTERHORN Phase 3 trial of roxadustat for anemia in patients with transfusion-dependent…
FibroGen Earnings Preview
FibroGen (NASDAQ:FGEN) is set to give its latest quarterly earnings report on Monday, 2023-05-08. Here’s what investors need…
FibroGen Shares Gain As Analyst Creates Bullish Pitch On Pulmonary Fibrosis Opportunity
William Blair has upgraded FibroGen Inc (NASDAQ:FGEN) from Market Perform To Outperform, citing a deep dive opportunity for its wholly owned monoclonal…
William Blair Upgrades FibroGen to Outperform
William Blair analyst Andy Hsieh upgrades FibroGen (NASDAQ:FGEN) from Market Perform to Outperform.